Average US Drug Price Rises Exceed CPI: NACDS
Pharmaceutical manufacturers' prices for the top 500 drugs dispensed inchain and independent community retail pharmacies in the USA saw an overall increase of 4.1% for 1996, according to the National Association of Chain Drug Stores' PRIME Index.
While the overall 4.1% rise measured by the NACDS was slightly less than the overall 4.6% reported for 1995, it is around 28% greater than the 3.2% Consumer Price Index increase at the end of 1996 compared with year-end 1995.
But Bureau Of Labor Figures Show 2.1% Hike The rate of increase of the top 500 prescription drugs has exceeded the overall CPI rate of increase each year since 1992, when the NACDS PRIME Index was established. However, there has long been a bone of contention regarding the NACDS figures, which do not compare with the Bureau of Labor Statistics' Producer Price Index; this indicates a 2.1% increase in prescription drug prices for 1996, compared with 4.2% for 1995.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze